CIL, MRM Proteomics Ink Supply Deal for Targeted Proteomics Assays | GenomeWeb

NEW YORK (GenomeWeb) – Cambridge Isotope Laboratories and MRM Proteomics said yesterday that they have signed an exclusive global supply agreement for mass spec-based targeted proteomics assays.

Under the agreement, CIL will have exclusive selling rights to MRM Proteomics' PeptiQuant kits used for quantitative proteomics and will provide distribution for the products worldwide.

The most widely used mass spec approach for targeted protein quantitation, MRM-MS assays typically incorporate stable isotope labeled (SIL) peptides to improve their accuracy and reproducibility.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.